Validation of diagnoses of liver disorders in users of systemic azole antifungal medication in Sweden.

Among patients who received azole antifungal treatment and were subsequently diagnosed with a liver disorder, the PPV for the diagnosis of jaundice was high, while the PPVs for toxic liver disease and hepatic failure were lower.